Saturday 17 October 2026
Export CGC’s income statement to Excel — free account
Canopy Growth Corporation
CGC Healthcare Drug Manufacturers Specialty & Generic
Canopy Growth Corporation’s revenue for fiscal 2026 (year ended March 2026) was $206.0 million, up 6.55% from fiscal 2025. In the quarter to June 2026, revenue grew 12.4%, EPS grew 87.5%, free cash flow fell 117.6% and total debt fell 18.7%, each against the same quarter a year earlier. Dividend growth for three consecutive years, operating cash flow growth for three.
0.71
0.03
−4.05%
Follow CGC
| Mar '17 | Mar '18 | Mar '19 | Mar '20 | Mar '21 | Mar '22 | Mar '23 | Mar '24 | Mar '25 | Mar '26 | |
|---|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
— | — | 2 | 2 | 4 | 2 | 4 | 5 | 4 | 5 |
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Altman Z-Score |
12.22 | 18.57 | 6.45 | 1.04 | 1.51 | (0.70) | (8.72) | (10.69) | (16.35) | (13.21) |
P/S ratio |
0.00 | 31.64 | 56.31 | 16.74 | 28.73 | 7.15 | 2.66 | 2.56 | 0.51 | 1.37 |
Altman Z″-Score (non-manufacturers) |
11.52 | 7.92 | 7.87 | 1.43 | (0.57) | (1.35) | (19.56) | (25.73) | (37.06) | (29.51) |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Beneish M-Score |
— | (1.24) | (0.66) | — | (4.36) | — | — | (4.49) | (4.71) | (3.49) |
P/Operating CF |
(57.00) | (154.41) | (65.31) | (30.32) | (168.58) | (28.83) | (7.14) | (31.04) | (4.01) | (20.96) |
P/B ratio |
2.51 | 4.54 | 2.06 | 1.31 | 4.51 | 1.03 | 1.41 | 1.52 | 0.28 | 0.56 |
Price to Tangible BV |
7.32 | 6.82 | 2.87 | 2.49 | 12.19 | 2.52 | 2.21 | 2.15 | 0.38 | 0.71 |
EV/Sales |
0.00 | 29.88 | 42.80 | 12.90 | 27.40 | 7.37 | 3.93 | 3.86 | 1.12 | 0.90 |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
0.00 | (65.35) | (21.74) | (6.66) | (32.16) | (7.03) | (2.84) | (4.07) | (1.82) | (3.99) |
EV/FCF |
0.00 | (20.52) | (9.40) | (3.44) | (26.02) | (6.77) | (2.86) | (8.69) | (1.76) | (3.65) |
Quick Ratio |
6.12 | 3.74 | 11.23 | 4.96 | 8.45 | 6.95 | 1.11 | 1.12 | 2.02 | 2.56 |
Current Ratio |
10.06 | 5.24 | 12.32 | 6.10 | 9.98 | 8.16 | 1.34 | 1.58 | 3.12 | 3.34 |
Net Debt/EBITDA |
10.06 | 4.97 | 6.73 | 0.99 | 0.65 | (0.12) | (0.19) | (2.20) | (2.25) | 1.09 |
Debt/Assets |
1.52% | 0.59% | 10.83% | 6.79% | 23.20% | 26.73% | 53.58% | 45.93% | 33.13% | 20.86% |
Debt/Equity |
0.02 | 0.01 | 0.13 | 0.09 | 0.45 | 0.42 | 1.72 | 1.19 | 0.62 | 0.33 |
Asset Turnover |
0.30 | 0.17 | 0.05 | 0.05 | 0.08 | 0.09 | 0.10 | 0.16 | 0.24 | 0.28 |
Operating CF/Net income |
1.63 | 1.16 | 0.76 | 0.58 | 0.27 | 1.81 | 0.17 | 0.43 | 0.28 | 0.24 |
Capex/Depreciation |
(4.86) | (8.69) | (14.55) | (5.77) | (0.86) | (0.18) | 0.04 | 2.82 | (0.15) | (0.16) |
Interest Coverage |
(230.43) | (62.44) | (11.95) | (27.05) | (55.57) | (163.57) | (120.68) | — | — | — |
| (4.49%) | (7.63%) | (16.10%) | (21.23%) | (40.80%) | (8.75%) | (144.08%) | (103.01%) | (119.21%) | (44.51%) | |
| (4.90%) | (6.71%) | (13.44%) | (16.82%) | (25.61%) | (5.00%) | (78.42%) | (34.69%) | (52.96%) | (25.90%) | |
ROIC |
(1.82%) | (5.63%) | (9.82%) | (29.17%) | (28.17%) | (18.23%) | (139.89%) | (16.12%) | (11.21%) | (18.00%) |
Return on Tangible Assets |
(6.48%) | (10.15%) | (11.91%) | (36.02%) | (48.09%) | (12.25%) | (424.15%) | (143.96%) | (121.15%) | (38.24%) |
Average Days of Receivables |
21.23 | 43.87 | 147.70 | 82.52 | 61.72 | 67.65 | 85.15 | 63.69 | 71.62 | 46.54 |
Research and Development Expense of Revenue |
0.81% | 0.82% | 5.76% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
38.57% | 73.56% | 229.17% | 254.28% | 121.93% | 99.99% | 120.97% | 81.98% | 61.50% | 57.71% |
Intangible Assets out of Total Assets |
0.60 | 0.29 | 0.24 | 0.35 | 0.32 | 0.38 | 0.11 | 0.11 | 0.15 | 0.13 |
Share Based Compensation of Revenue |
10.05% | 28.71% | 108.86% | 80.32% | 16.67% | 9.13% | 7.74% | 4.77% | (1.56%) | 1.50% |
Graham Net Nets |
0.07 | 0.05 | 0.24 | 0.12 | (0.03) | (0.08) | (0.56) | (0.56) | (1.00) | 0.28 |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
(1.38%) | (1.08%) | (4.80%) | (20.86%) | (11.27%) | (7.39%) | (332.00%) | (84.73%) | (443.96%) | (61.51%) |
Free Cash Flow Yield |
0.00% | (4.60%) | (8.08%) | (22.39%) | (3.66%) | (15.24%) | (51.69%) | (17.36%) | (126.37%) | (17.83%) |
Revenue per Share |
6.40 | 7.84 | 7.54 | 8.61 | 11.15 | 10.61 | 6.57 | 2.95 | 1.80 | 0.69 |
Operating CF per Share |
(1.73) | (3.59) | (14.86) | (16.69) | (9.50) | (11.13) | (9.10) | (2.79) | (1.11) | (0.15) |
Capex per Share |
(1.89) | (7.84) | (19.49) | (15.59) | (2.24) | (0.42) | 0.05 | 1.49 | (0.04) | (0.01) |
Free Cash Flow per Share |
(3.62) | (11.42) | (34.34) | (32.28) | (11.74) | (11.55) | (9.05) | (1.31) | (1.15) | (0.17) |
Cash per Share |
6.55 | 14.19 | 128.86 | 43.16 | 47.12 | 28.21 | 12.96 | 2.09 | 0.92 | 0.90 |
Shareholders Equity per Share |
39.36 | 54.71 | 206.67 | 110.34 | 71.10 | 73.28 | 12.40 | 4.96 | 3.26 | 1.69 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
39.36 | 54.71 | 206.67 | 110.34 | 71.10 | 73.28 | 12.40 | 4.96 | 3.26 | 1.69 |
Free Cash Flow |
(43.11) | (202.54) | (916.88) | (1,123.59) | (436.26) | (452.07) | (419.47) | (97.77) | (123.69) | (50.49) |
Working Capital |
121.92 | 304.08 | 3,549.76 | 1,611.70 | 1,935.57 | 1,216.25 | 206.84 | 101.16 | 143.86 | 268.55 |
Capital Expenditures |
(22.47) | (138.95) | (520.25) | (542.73) | (83.28) | (16.62) | 2.31 | 111.24 | (4.56) | (4.31) |
Net Current Asset Value |
87.48 | 224.85 | 2,727.80 | 612.53 | (378.01) | (226.06) | (455.28) | (317.75) | (97.68) | 78.41 |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.30 | 1.00 | 2.58 | 1.81 | 0.20 | 0.04 | (0.01) | (0.50) | 0.02 | 0.02 |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.06 | 0.07 | 0.04 | 0.08 | 0.12 | 0.12 | 0.17 | 0.17 | 0.15 | 0.12 |
Cash ROIC |
(7.78%) | (16.49%) | (9.47%) | (19.74%) | (7.80%) | (8.75%) | (19.38%) | (10.08%) | (18.52%) | (5.36%) |
Accounts Receivable Turnover |
29.27 | 13.15 | 4.10 | 4.02 | 6.01 | 5.65 | 4.12 | 4.02 | 5.06 | 6.42 |
Accounts Payable Turnover |
6.90 | 1.99 | 1.10 | 2.44 | 5.06 | 11.13 | 7.04 | 4.06 | 6.81 | 7.08 |
Inventory Turnover |
1.56 | 1.18 | 0.76 | 1.17 | 1.27 | 2.58 | 2.78 | 1.89 | 2.15 | 2.08 |
Average Days of Payables |
90.11 | 314.18 | 471.34 | 104.63 | 51.18 | 32.88 | 54.88 | 48.39 | 50.27 | 59.13 |
Days of Inventory on Hand |
349.19 | 413.75 | 709.67 | 331.62 | 280.00 | 104.57 | 107.19 | 130.45 | 185.64 | 187.67 |
Average Receivables |
2.60 | 10.57 | 49.12 | 74.65 | 68.92 | 73.50 | 74.02 | 54.77 | 38.18 | 32.10 |
Average Payables |
6.88 | 40.80 | 121.25 | 132.69 | 71.87 | 51.13 | 54.47 | 39.46 | 20.01 | 21.98 |
Average Inventory |
30.46 | 68.73 | 175.97 | 276.96 | 286.45 | 220.98 | 137.85 | 84.97 | 63.28 | 74.63 |
Average Assets |
258.10 | 818.60 | 3,887.32 | 5,904.64 | 5,163.58 | 4,825.60 | 3,162.43 | 1,404.56 | 811.74 | 734.64 |
Average Common Equity |
282.05 | 719.14 | 3,243.98 | 4,679.13 | 3,241.36 | 2,754.98 | 1,721.24 | 472.99 | 360.59 | 427.54 |
Columns are period end dates